engpass.radarSwiss drug shortages
Back to overview
Historical entry
G03GA056 days reported

GONAL-F Trockensub 1050 IE (77 mcg) Inj kit

Details

Manufacturer
Merck (Schweiz) AG
ATC code
G03GA05
Status
9 abgeschlossen
Reported since
6 days
First report
09.07.2021
Product information (AIPS)
swissmedicinfo.ch →

Overview

GONAL-F Trockensub 1050 IE (77 mcg) Inj kit is a medication by Merck (Schweiz) AG. This entry is marked as resolved — the documented shortage lasted 6 days. Switzerland has 8 other products approved with the same active substance — none are currently available.

Available alternatives

No alternatives with the same active substance are currently available.

Frequently asked questions

What can I do if GONAL-F Trockensub 1050 IE (77 mcg) Inj kit is unavailable?

Contact your pharmacy or treating physician. Substitution with a product containing the same active substance is often possible. Available alternatives are listed above on this page.

What alternatives exist for GONAL-F Trockensub 1050 IE (77 mcg) Inj kit?

Available alternatives are listed above. Pharmacies can dispense a generic or alternative brand with the same active substance after consulting with the doctor.

When will GONAL-F Trockensub 1050 IE (77 mcg) Inj kit be available again?

The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.

Why is GONAL-F Trockensub 1050 IE (77 mcg) Inj kit unavailable?

Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.

Where do I report a shortage of GONAL-F Trockensub 1050 IE (77 mcg) Inj kit?

Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.

Source: drugshortage.ch · no warranty of completeness